| abstract |
Described herein are compounds that are estrogen receptor modulators of formula (I), and stereoisomers, tautomers or pharmaceutically acceptable salts thereof, wherein SERMF is , Selective estrogen receptor modulator fragments having the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments comprising the compounds described herein, and such estrogen receptors for treating diseases or conditions that are mediated or dependent on estrogen receptors. This method uses the modulator alone or in combination with other compounds. [Selection figure] None |